Publications

Find at Harvard

Register to Read

2019
Working Paper

Who Drives Digital Innovation? Evidence from the U.S. Medical Device Industry

By: Cirrus Foroughi and Ariel Dora Stern

Does the large-scale technological change that is characteristic of an industry-wide digital transformation entrench industry leaders or enable the rise of new entrants? We offer a novel approach to this question by studying the medical device industry, a unique... View Details

Keywords: Innovation; Medical Devices; Digitization; Medical Technology; Technological Innovation; Applications and Software; Market Entry and Exit; Industry Growth; Medical Devices and Supplies Industry; United States

Read Now

2013
Working Paper

How the Zebra Got Its Stripes: Imprinting of Individuals and Hybrid Social Ventures

By: Matthew Lee and Julie Battilana

Hybrid organizations that combine multiple, existing organizational forms are frequently proposed as a source of organizational innovation, yet little is known about the origins of such organizations. We propose that individual founders of hybrid organizations acquire... View Details

Keywords: Hybrid Organizations; Imprinting; Institutional Theory; Social Entrepreneurship; Organizations

SSRN

Read Now

Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details

01 Nov 2012
HBS Seminar

Joel Waldfogel, University of Minnesota

February 2009 (Revised December 2010)
Case

Upgrading the Economy: Industrial Policy and Taiwan's Semiconductor Industry

By: Willy C. Shih and Jyun-Cheng Wang

The government-led creation and incubation of the semiconductor industry in Taiwan is a striking success for advocates of strong industrial policy. It has led to the island nation's domination of the global "foundry" business in which firms like Taiwan Semiconductor... View Details

Keywords: Economic Growth; Industry Structures; State Ownership; Business and Government Relations; Competition; Semiconductor Industry; Taiwan

July 1997 (Revised April 1998)
Case

Chase Manhattan Corporation: The Making of America's Largest Bank

By: Stuart C. Gilson and Cedric Escalle

Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details

Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States

2024
Working Paper

Magnetic Resonance Imaging—High Quality and Radiation Free: Case Histories of Transformational Advances

By: Srikant M. Datar, Amar Bhidé and Katherine Stebbins

This case history describes how Magnetic Resource Imaging (MRI) came to complement – and partially replace -- computed tomography (CT) imaging of soft tissue. Specifically, we chronicle 1) the development of foundational techniques and prototypes (through the 1970s);... View Details

Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms

SSRN

Read Now

February 2013 (Revised February 2013)
Case

King Abdullah Economic City in 2009: Population Drivers and Cash Flow

By: John D. Macomber

CEO of high profile new economic city in Saudi Arabia must decide how to allocate limited investment funds across projects under duress. Issues include understanding core economic drivers, planning infrastructure investment and return, attracting multinationals, energy... View Details

Keywords: Urban Development; Infrastructure; Real Estate Industry; Saudi Arabia

Web

Alumni

early advocate for commercial indexing, an approach that has since become a central tenet of modern investment strategy. In 1977, Grantham cofounded GMO, where he continues to serve as the long-term investment strategist and is part of... View Details

September 2023 (Revised January 2025)
Case

To Found or to Cofound? That is the Question

By: Christina Wallace and Jo Tango

Entrepreneurs often struggle with the question of whether to found solo or alongside one or more cofounders. This case is comprised of three vignettes detailing common founding scenarios: the first-time technical founder; the serial commercial founder; and the MBA... View Details

Keywords: Business Startups; Decisions; Entrepreneurship; Partners and Partnerships

December 2023
Case

Davivienda Bank's Upskilling and Reskilling Strategy in Colombia

By: Jorge Tamayo, Raffaella Sadun and Jenyfeer Martinez Buitrago

Set in 2022, this case describes the digital transformation strategy of Davivienda— a leading player in Colombia’s commercial banking and one of the companies belonging to Grupo Bolívar, a major Colombian financial conglomerate—and the bank’s upskilling and reskilling... View Details

August 2009 (Revised March 2011)
Case

Shenzhen Development Bank

By: Li Jin, Yuhai Xuan and Xiaobing Bai

Weijian Shan, Managing Partner of Newbridge Capital, faces a tough call in regard to his firm's investment in Shenzhen Development Bank, China's fifteenth-largest commercial bank listed on the Shenzhen Stock Exchange. Due to the aggressive lobby of the existing... View Details

Keywords: Mergers and Acquisitions; Private Equity; Commercial Banking; Investment; Emerging Markets; Business and Government Relations; Banking Industry; China

January 2022
Case

SpartanNash Company: The Amazon Warrants (A)

By: Benjamin C. Esty, E. Scott Mayfield and Daniel Fisher

As of 12/31/21, Amazon held $22 billion of equity and warrants in related companies. In fact, it often requests a free grant of warrants when it enters into a new commercial agreement with a supplier. Over the past 20 years, Amazon has gotten warrants in almost 20... View Details

Keywords: Valuation; Value Creation; Consumer Behavior; Negotiation; Distribution; Ownership; Partners and Partnerships; Business Strategy; Equity; Distribution Industry; Food and Beverage Industry; United States

August 2024
Case

Iogen: Decarbonizing Hard-to-Abate Sectors

By: George Serafeim, Charlotte Foody and John Mulliken

Brian Foody, CEO of Iogen Corporation, was an early leader in advanced biofuels, developing a range of technologies to transform agricultural waste into transportation fuel. With $100 million in revenue and 350 patents across various biofuel technologies, Iogen was... View Details

Keywords: Technology; Biofuel; Market Attractiveness; Decarbonization; Technological Innovation; Climate Change; Energy; Environmental Sustainability; Transformation; Market Entry and Exit; Strategy; Energy Industry; United States; United Kingdom

Research Summary

Science-Based Business and the Business of Science

By: H. Kent Bowen

Science and technology can provide strategic advantage to companies' through differentiated products and processes. The focus of our research is on unusually productive and creative labs that are the sources of breakthroughs that create platforms for sustained... View Details

February 2007 (Revised April 2010)
Case

Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics

By: Robert S. Huckman, Gary P. Pisano and Mark Rennella

Describes the reorganization of the drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and (2) institute numerical metrics--jointly affecting all R&D scientists--for the progression... View Details

Keywords: Decision Making; Measurement and Metrics; Business Processes; Organizational Structure; Research and Development; Science-Based Business; Creativity; Pharmaceutical Industry

01 Jun 2015
News

Business Lending Is Up, But Probably Not for You

08 Feb 2022
News

Deep Purpose with Ranjay Gulati

April 1998
Case

Cephalon, Inc.

By: Peter Tufano

In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to... View Details

Keywords: Risk Management; Financing and Loans; Health Care and Treatment; Pharmaceutical Industry; United States